BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 11159547)

  • 21. [Genetic and proteinic analysis of a Chinese boy with X-linked lymphoproliferative disease and his maternal relatives].
    Yang X; Wang J; An YF; Kanegane H; Miyawaki T; Zhao XD
    Zhonghua Er Ke Za Zhi; 2011 Jun; 49(6):416-20. PubMed ID: 21924052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SAP controls the cytolytic activity of CD8+ T cells against EBV-infected cells.
    Dupré L; Andolfi G; Tangye SG; Clementi R; Locatelli F; Aricò M; Aiuti A; Roncarolo MG
    Blood; 2005 Jun; 105(11):4383-9. PubMed ID: 15677558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The X-linked lymphoproliferative syndrome gene product SH2D1A associates with p62dok (Dok1) and activates NF-kappa B.
    Sylla BS; Murphy K; Cahir-McFarland E; Lane WS; Mosialos G; Kieff E
    Proc Natl Acad Sci U S A; 2000 Jun; 97(13):7470-5. PubMed ID: 10852966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sustained elevation of serum interleukin-18 and its association with hemophagocytic lymphohistiocytosis in XIAP deficiency.
    Wada T; Kanegane H; Ohta K; Katoh F; Imamura T; Nakazawa Y; Miyashita R; Hara J; Hamamoto K; Yang X; Filipovich AH; Marsh RA; Yachie A
    Cytokine; 2014 Jan; 65(1):74-8. PubMed ID: 24084330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation-dependent T cell expression of the X-linked lymphoproliferative disease gene product SLAM-associated protein and its assessment for patient detection.
    Shinozaki K; Kanegane H; Matsukura H; Sumazaki R; Tsuchida M; Makita M; Kimoto Y; Kanai R; Tsumura K; Kondoh T; Moriuchi H; Miyawaki T
    Int Immunol; 2002 Oct; 14(10):1215-23. PubMed ID: 12356686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency).
    Pachlopnik Schmid J; Canioni D; Moshous D; Touzot F; Mahlaoui N; Hauck F; Kanegane H; Lopez-Granados E; Mejstrikova E; Pellier I; Galicier L; Galambrun C; Barlogis V; Bordigoni P; Fourmaintraux A; Hamidou M; Dabadie A; Le Deist F; Haerynck F; Ouachée-Chardin M; Rohrlich P; Stephan JL; Lenoir C; Rigaud S; Lambert N; Milili M; Schiff C; Chapel H; Picard C; de Saint Basile G; Blanche S; Fischer A; Latour S
    Blood; 2011 Feb; 117(5):1522-9. PubMed ID: 21119115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinct interactions of the X-linked lymphoproliferative syndrome gene product SAP with cytoplasmic domains of members of the CD2 receptor family.
    Lewis J; Eiben LJ; Nelson DL; Cohen JI; Nichols KE; Ochs HD; Notarangelo LD; Duckett CS
    Clin Immunol; 2001 Jul; 100(1):15-23. PubMed ID: 11414741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The abnormal gene in X-linked lymphoproliferative syndrome.
    Sullivan JL
    Curr Opin Immunol; 1999 Aug; 11(4):431-4. PubMed ID: 10448142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. X-Linked Lymphoproliferative Syndrome: A Spectrum of Clinical and Immunological Profile and Novel Pathogenic Variants from Chandigarh, India.
    Jindal AK; Mondal S; Sil A; Rawat A; Chawla S; Tyagi R; Sudhakar M; Banday AZ; Suri D; Vignesh P; Dhaliwal M; Sharma S; Rikhi R; Saka R; Sharma R; Chatterjee D; Sreedharanunni S; Uppuluri R; Raj R; Singh S
    Int Arch Allergy Immunol; 2024; 185(4):370-381. PubMed ID: 38194943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening the PRF1, UNC13D, STX11, SH2D1A, XIAP, and ITK gene mutations in Chinese children with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
    Zhizhuo H; Junmei X; Yuelin S; Qiang Q; Chunyan L; Zhengde X; Kunling S
    Pediatr Blood Cancer; 2012 Mar; 58(3):410-4. PubMed ID: 21674762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early and rapid detection of X-linked lymphoproliferative syndrome with SH2D1A mutations by flow cytometry.
    Zhao M; Kanegane H; Kobayashi C; Nakazawa Y; Ishii E; Kasai M; Terui K; Gocho Y; Imai K; Kiyasu J; Nonoyama S; Miyawaki T
    Cytometry B Clin Cytom; 2011 Jan; 80(1):8-13. PubMed ID: 20632414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cellular and molecular pathogenesis of X-linked lymphoproliferative disease.
    Moretta A; Bottino C; Parolini S; Moretta L; Biassoni R; Notarangelo LD
    Curr Opin Allergy Clin Immunol; 2001 Dec; 1(6):513-7. PubMed ID: 11964734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. X-linked Lymphoproliferative Disease Type 1 in a Patient With the p.Gly93Asp SH2D1A Gene Mutation and Hemophagocytic Lymphohistiocytosis.
    de la Varga-Martínez R; Mora-López F; García-Cuesta D; Garrastazul-Sánchez MP; Quintero S; Rodríguez C; Sampalo A
    J Pediatr Hematol Oncol; 2017 Nov; 39(8):e483-e485. PubMed ID: 28816794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Variable clinical phenotypes of X-linked lymphoproliferative syndrome in China: Report of five cases with three novel mutations and review of the literature.
    Jin YY; Zhou W; Tian ZQ; Chen TX
    Hum Immunol; 2016 Aug; 77(8):658-666. PubMed ID: 27288720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [X-linked lymphoproliferative syndrome, EBV virus infection and defects in cytotoxicity lymphocyte regulation].
    Malbrán A; Belmonte L; Ruibal-Ares B; Baré P; Bracco MM
    Medicina (B Aires); 2003; 63(1):70-6. PubMed ID: 12673966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical and gene research of X-linked lymphoproliferative disease in a Chinese family].
    Zhu DX; Du J; Lan HK; Yu L; Feng ZC
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(4):244-8. PubMed ID: 17425868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. X-linked lymphoproliferative disease: three atypical cases.
    Nistala K; Gilmour KC; Cranston T; Davies EG; Goldblatt D; Gaspar HB; Jones AM
    Clin Exp Immunol; 2001 Oct; 126(1):126-30. PubMed ID: 11678908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epstein-Barr virus LMP1 inhibits the expression of SAP gene and upregulates Th1 cytokines in the pathogenesis of hemophagocytic syndrome.
    Chuang HC; Lay JD; Hsieh WC; Wang HC; Chang Y; Chuang SE; Su IJ
    Blood; 2005 Nov; 106(9):3090-6. PubMed ID: 16002423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fatal hemophagocytic lymphohistiocytosis associated with Epstein-Barr virus infection in a patient with a novel mutation in the signaling lymphocytic activation molecule-associated protein.
    Halasa NB; Whitlock JA; McCurley TL; Smith JA; Zhu Q; Ochs H; Dermody TS; Crowe JE
    Clin Infect Dis; 2003 Nov; 37(10):e136-41. PubMed ID: 14583885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of an SH2D1A mutation in a hypogammaglobulinemic male patient with a diagnosis of common variable immunodeficiency.
    Aghamohammadi A; Kanegane H; Moein M; Farhoudi A; Pourpak Z; Movahedi M; Gharagozlou M; Zargar AA; Miyawaki T
    Int J Hematol; 2003 Jul; 78(1):45-7. PubMed ID: 12894850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.